story of the week
Adjuvant Tamoxifen and Exemestane in Women With Postmenopausal Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Tamoxifen and Exemestane in Women With Postmenopausal Early Breast Cancer (TEAM): 10-Year Follow-Up of a Multicentre, Open-Label, Randomised, Phase 3 Trial
Lancet Oncol 2017 Jul 18;[EPub Ahead of Print], MGM Derks, EJ Blok, C Seynaeve, JWR Nortier, EM Kranenbarg, GJ Liefers, H Putter, JR Kroep, D Rea, A Hasenburg, C Markopoulos, R Paridaens, JBE Smeets, LY Dirix, CJH van de VeldeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.